Tandem Diabetes Care (TNDM) had the highest return between December 1, 2017 and March 31, 2019 by a mid-cap US stock, returning 2,251.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Tandem Diabetes Care (TNDM) | 12/1/2017 - 3/31/2019 | 2,251.85% |
Arrowhead Pharmaceuticals (ARWR) | 12/1/2017 - 3/31/2019 | 416.9% |
Xenon Pharmaceuticals (XENE) | 12/1/2017 - 3/31/2019 | 314.69% |
Etsy (ETSY) | 12/1/2017 - 3/31/2019 | 308.63% |
Vericel Corp Ord (VCEL) | 12/1/2017 - 3/31/2019 | 284.84% |
Veracyte (VCYT) | 12/1/2017 - 3/31/2019 | 267.94% |
Magnite (MGNI) | 12/1/2017 - 3/31/2019 | 237.78% |
Viking Therapeutics (VKTX) | 12/1/2017 - 3/31/2019 | 225.9% |
Enphase Energy (ENPH) | 12/1/2017 - 3/31/2019 | 220.49% |
Ascendis Pharma A-S (ASND) | 12/1/2017 - 3/31/2019 | 218.19% |
Krystal Biotech (KRYS) | 12/1/2017 - 3/31/2019 | 213.63% |
Glaukos (GKOS) | 12/1/2017 - 3/31/2019 | 194.85% |
PAR Technology (PAR) | 12/1/2017 - 3/31/2019 | 182.77% |
Guardant Health (GH) | 12/1/2017 - 3/31/2019 | 176.4% |
Rapid7 (RPD) | 12/1/2017 - 3/31/2019 | 168.77% |
Axsome Therapeutics (AXSM) | 12/1/2017 - 3/31/2019 | 165.98% |
Sunrun (RUN) | 12/1/2017 - 3/31/2019 | 152.42% |
Madrigal Pharmaceuticals (MDGL) | 12/1/2017 - 3/31/2019 | 149.03% |
Novocure (NVCR) | 12/1/2017 - 3/31/2019 | 143.28% |
Goosehead Insurance (GSHD) | 12/1/2017 - 3/31/2019 | 136.24% |
Crocs (CROX) | 12/1/2017 - 3/31/2019 | 136.02% |
PTC Therapeutics (PTCT) | 12/1/2017 - 3/31/2019 | 135.54% |
Workiva (WK) | 12/1/2017 - 3/31/2019 | 135.27% |
Inspire Medical Systems (INSP) | 12/1/2017 - 3/31/2019 | 131.85% |
First Bancorp (FBP) | 12/1/2017 - 3/31/2019 | 130.12% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
